Inflammatory Response Research, Inc. develops pharmaceutical products to treat inflammatory disorders and conditions. Its current focus is a therapeutic for global COVID-19 treatment and a ‘First Response’ injectable for acute inflammation.
Oscar B. (Bud) Marx III chaired Gentherm Inc. from 1999 until retiring in May 2017. Gentherm supplied proprietary seat cooling and heating products to the global auto industry.
Jonathan Gilthorpe is Group Leader in Translational Neuroscience at Umeå University and has more than 20 years of basic and preclinical research experience. His group studies pathways associated with neural responses to neurotrauma and neurodegeneration.
The page lists B. Chandler May as president and CEO, Loriel May as CFO, William Pedranti and George Ng as advisors, and Mark Benedict as patent counsel.
Loriel May co-founded Inflammatory Response Research, Inc. in 2011 and has served as CFO since then. Before founding IRR, May was Corporate Controller and Treasurer for IntriPlex Technologies, Inc.
Inflammatory Response Research, Inc. 515 E. Micheltorena, Suite GSanta Barbara, Ca. 93103 Tel: 805-681-1522Mobile: 805-403-2320E-mail: bcmay@irrinc.net